Pegerythropoietin Injection (RD01)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegerythropoietin Injection (RD01), covering 2020-01-18 to 2020-01-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis [Phase 2]